Medical Doctor Program year 2025 Reported 2022–2025 Source: CMS Open Payments, 2026 publication

Joseph Firriolo

Plastic Surgery Boston, MA Medical Doctor

NPI 1306333505 CMS profile 11419977

300 Longwood Ave, Boston, MA 02115

Open in the dashboard

General payments

$4,035

31 records reported · program years 2022–2025

Research payments

$0

Paid to them · None reported · program years 2022–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Joseph Firriolo of Boston, MA is reported in the CMS Open Payments database as having received $4,035 across 31 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 66th percentile of Plastic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $289 2
2024 General $1,430 15
2023 General $415 4
2022 General $1,901 10

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Joseph Firriolo
  • Plastic Surgery median
  • Middle half of Plastic Surgery
  • National median

In program year 2025, general payments to Joseph Firriolo were reported at $289. Among 3,701 Plastic Surgery profiles paid that year, the median was $379 and the middle half received between $138 and $1,100.

Show as a table
Year Joseph Firriolo Plastic Surgery median Middle half National median
2019 $0 $371 $122–$1,483 $163
2020 $0 $158 $52–$438 $114
2021 $0 $249 $87–$752 $132
2022 $1,901 $274 $102–$793 $149
2023 $415 $299 $113–$891 $160
2024 $1,430 $361 $124–$1,062 $164
2025 $289 $379 $138–$1,100 $169

Breakdown

Who paid General payments · program years 2022–2025
  1. Evolution Surgical, Inc $1,244 3 payments
  2. Medical Device Business Services, Inc. $854 7 payments
  3. Allergan Inc. $511 6 payments
  4. Integra LifeSciences Corporation $465 4 payments
  5. Innovation Technologies Inc $269 4 payments
  6. KCI USA, Inc $141 1 payment
  7. Dilon Technologies, Inc. $135 1 payment
  8. Stryker Corporation $129 1 payment
  9. AbbVie, Inc. $125 1 payment
  10. Mentor Worldwide LLC $95 2 payments
  11. Other $68 1 payment

Every payment, record by record

What the payments were for General payments · program years 2022–2025
  1. Food and Beverage $1,871 25 payments
  2. Education $1,200 1 payment
  3. Travel and Lodging $704 4 payments
  4. Grant $260 1 payment
Products named General payments · program years 2022–2025
  1. NATRELLE SALINE-FILLED BREAST IMPLANTS $511 6 payments
  2. Integra Recon-Skin And Wound $316 3 payments
  3. Integra Recon-Skin And Wound $316 3 payments
  4. Integra Recon-Skin And Wound $316 3 payments
  5. INTEGRA DERMAL REGENERATION TEMPLATE $316 3 payments
  6. PRIMATRIX $316 3 payments
  7. Irrisept $269 4 payments
  8. SURGIMEND $149 1 payment
  9. V.A.C. VERAFLO $141 1 payment
  10. HEMOBLAST BELLOWS $135 1 payment
  11. Other $431 6 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

31 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Plastic Surgery in Massachusetts

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record